When.com Web Search

  1. Ads

    related to: best statin for elderly women over 80 percent

Search results

  1. Results From The WOW.Com Content Network
  2. Older adults over age 70 should consider taking statins ...

    www.aol.com/older-adults-over-age-70-151519096.html

    When examining the cost-effectiveness of statin use in older adults, the researchers report that statins were cost-effective, with the cost per quality-adjusted life years gained below £3,502 ...

  3. Statins are Effective Even for People Over Age 75, What ... - AOL

    www.aol.com/statins-effective-even-people-over...

    Statins appear to be effective at preventing cardiovascular disease and death in older adults, according to new research. Most clinical trials evaluating statins have not included people 75 and ...

  4. Why Women are Less Likely to be Prescribed Cholesterol ...

    www.aol.com/why-women-less-likely-prescribed...

    Five percent of women were treated with statins compared to ... 80 and older. Statin prescriptions for women, men ... The authors noted that over a 21-year period, women were diagnosed later than ...

  5. Rosuvastatin - Wikipedia

    en.wikipedia.org/wiki/Rosuvastatin

    Over the dose range of 1 to 80 mg/day strong linear dose‐related effects were found; total cholesterol was reduced by 22.1% to 44.8%, LDL cholesterol by 31.2% to 61.2%, non-HDL cholesterol by 28.9% to 56.7% and triglycerides by 14.4% to 26.6%.

  6. Statin - Wikipedia

    en.wikipedia.org/wiki/Statin

    Statins have been studied for improving operative outcomes in cardiac and vascular surgery. [41] Mortality and adverse cardiovascular events were reduced in statin groups. [42] Older adults who receive statin therapy at time of discharge from the hospital after an inpatient stay have been studied. People with cardiac ischemia not previously on ...

  7. JUPITER trial - Wikipedia

    en.wikipedia.org/wiki/JUPITER_trial

    JUPITER was a randomized double-blind placebo-controlled study investigating the use of rosuvastatin in the primary prevention of cardiovascular disease.The trial focused on patients with normal low-density lipoprotein (LDL) cholesterol levels but increased levels of high-sensitivity C-reactive protein (hs-CRP).